Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abbvie, Aikido, Amyris, Athersys, Basilea, Beigene, Bial, Biohaven, Bionomics, Biontech, Boston Immune Technologies and Therapeutics, Cellular Biomedicine, Cend, China SXT, Eisai, Empathbio, Evolus, Glaxosmithkline, GT, Hansoh, Healios, Hikma, Huadong Medicine, Marinomed, Medytox, Moderna, Nascent, Neuren, Nicox, Novavax, Open Orphan, Pfizer, Provention, Qilu, Recce, Santen, Scynexis, Shenzhen Hepalink, SK Group, Vaxil Bio, Vir.